GLUCOCARD W KITA

Description:
High accuracy: GLUCOCARD W was designed to be compliant with the new requirements in EN ISO 15197:2015
7 seconds measuring time: The measurement result is displayed in just 7 seconds from blood detection.
0.5μL micro sampling: Only a 0.5 µL blood sample is needed to perform measurement.
USB port data download (micro USB): The meter has a data download port to export the result data to an external PC.
Safe test strip disposal leaver: The meter has a test strip disposal lever which helps keep your hands clean and helps avoid contact with blood.

Glucocard W Test Strips

Description: Glucocard W Test Strips

Nictur 360 micrograms/ml oral solution, 15ml

Composition: Desmopressin 360 mcg/ml Indication: Central diabetes insipidus, a disease characterized by causing extreme thirst and continuous production of large volumes of dilute urine as a result of an insufficient production of the hormone vasopressin. Bed-wetting (involuntary nightly urination or primary nocturnal enuresis) in patients older than 5 years with normal capacity of concentrate urine. Nocturia (frequent urination during the night) in adults. Please read section 2 carefully for important information on the safe use of Desmopressin in this case.

Resincolesteramina, Powder for oral suspension, 50 sachets

Composition: Cholestyramine 4g Indication: RESINCOLESTIRAMINA belongs to a group of medicines called ion exchange resins, which bind to bile acids. It is used to lower the levels of cholesterol (a type of fat) in the body, that can cause heart problems. The medicine acts in the bowel, binding to bile acids that contain cholesterol. Thereby avoiding its absorption, and eliminating it in the stools. RESINCOLESTIRAMINA can also be used to treat a specific type of itching caused by bile retention (biliary stasis).

SIMPLA 5mg/100ml, injectable solution, 1 vial

Composition: Zoledronic acid 5mg/100ml
Indication: Treatment and prevention of Osteoporosis in post-menopausal women. Treatment to increase bone mass in men with osteoporosis. Prevention and treatment of Glucocorticoid-induced osteoporosis in patients to be treated with glucocorticoids for at least one year. Treatment of Pagel's bone disease in men and women.